As it consolidates wins across the several areas it competes in, the ADX-listed investment heavyweight Alpha Dhabi has more than quadrupled its revenues to a massive AED 39.64B for 2022. From AED 5.16B, the profit was AED 10.6B. Management confirms its commitment to support and enhance core activities of the Group to attain continuous growth,” said a statement.
Alpha Dhabi is a prominent stakeholder in Aldar in Abu Dhabi, as well as a big investment in Pure Health, which is developing as one of the country’s most systemically important healthcare businesses.
Alpha Dhabi’s asset base was valued at AED 13.71B at the end of December last year, a significant increase from AED 47.34B the previous year. In addition, the firm is part of the IHC portfolio, with IHC purchasing a 45% share in April 2021. Alpha Dhabi has a market capitalization of AED 231B, and its share price rose 1.49% to Dh 23.16 on Thursday.
